Lazard Asset Management
CANO

Lazard Asset Management’s Cano Health, Inc. CANO Stock Holding History

Lazard Asset Management’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-263
Closed -$228K – 2607
2022
Q3 		$228K Buy
+263
New +$165K ﹤0.01% 1251

Other funds holding CANO

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Lazard Asset Management's CANO Position: Q4 2022 in Review

Lazard Asset Management sold out of Cano Health, Inc. (CANO) in Q4 2022, closing a stake of 263 shares — an estimated $228K sold.

Lazard Asset Management first reported a position in CANO in Q3 2022 and held it in 1 quarter. The position peaked at $228K in Q3 2022. 186 funds tracked by Wall St. Rank hold CANO as of Q4 2022.

  • Lazard Asset Management reported no remaining Cano Health, Inc. position as of Q4 2022 after selling out during the quarter.
  • Lazard Asset Management sold 263 Cano Health, Inc. shares in Q4 2022, an estimated $228K.
  • Lazard Asset Management first reported a position in Cano Health, Inc. in Q3 2022 and held it in 1 quarter.
  • Lazard Asset Management's Cano Health, Inc. position peaked at $228K in Q3 2022.
  • 186 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2022.

Based on Lazard Asset Management's 13F filing for Q4 2022, filed 15 Feb 2023.